Drawing for SPECIFIC BIOLOGICS

USPTO serial 90975318

SPECIFIC BIOLOGICS

Reviewed by CopyMark Law Group

Reg. 6511636Status 700Renewal
Filing date
Status date
Registration date
Oct 5, 2021
Examiner
PIERCE, ALEXANDRA
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with SPECIFIC BIOLOGICS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*

Plus Government fees of $325

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
042Pharmaceutical products development; Pharmaceutical research and development, namely, research in the field of gene editing; Pharmaceutical research services; Biomedical research services; Biotechnology research, namely, in the field of genetic editing; Clinical research in the field of gene editing; Drug discovery services; Medical and scientific research in the field of cancer treatment; Medical and scientific research in the field of treatment of rare genetic diseases and disorders; Medical research; Medical research services, namely, for the treatment of cystic fibrosis and lung cancer; Providing laboratory research services in the field of gene expression, namely, cancer biology; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Research in the field of genetic editing; Research on the subject of pharmaceuticals, namely, pharmaceuticals to treat genetic disorders, cystic fibrosis and lung cancer; Scientific investigations for medical purposes; Scientific research in the field of oncology; Scientific study and research in the field of oncology; Technical consulting in the field of pharmaceutical studies; Technical research in the field of pharmaceutical studiesACTIVEMay 31, 2017

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 5, 2026REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jun 3, 2026WOAGWITHDRAWAL OF ATTORNEY GRANTED—
Jun 3, 2026WOARTEAS WITHDRAWAL OF ATTORNEY RECEIVED—
Dec 16, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Dec 16, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 16, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Oct 5, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 12, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Aug 12, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 12, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 20, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 20, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 30, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 17, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 17, 2021DPCCDIVISIONAL PROCESSING COMPLETE—
Jun 17, 2021AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
May 21, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 21, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 19, 2021DRRRDIVISIONAL REQUEST RECEIVED—
May 19, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 19, 2021ERTDTEAS REQUEST TO DIVIDE RECEIVED—
Nov 29, 2020GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 29, 2020GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 29, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 28, 2020DOCKASSIGNED TO EXAMINER—
Sep 3, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 31, 2020AMPXPRELIMINARY/VOLUNTARY AMENDMENT - ENTERED—
Aug 30, 2020ALIEASSIGNED TO LIE—
Aug 10, 2020PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Aug 8, 2020NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance